The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia.
Saved in:
| Title: | The Impact of Post-Hematopoietic Stem Cell Transplant Tyrosine Kinase Inhibitors in Philadelphia-Positive Acute Lymphoblastic Leukemia. |
|---|---|
| Authors: | Halahleh K; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Al Rimawi D; Biostatistics Unit, Research Office, King Hussein Cancer Center, Amman, Jordan., Abu Ghosh A; Department of Pediatrics, Medical Oncology-Hematology, King Hussein Cancer Center, Amman, Jordan., Muradi I; Department of Internal Medicine, University of Tripoli, Tripoli, Libya., Da'na W; Department of Medical Oncology-Hematology, Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan., Hamadani M; Internal Medicine, Division of Hematology & Oncology, Medical College of Wisconsin, Wauwatosa, WI, USA. |
| Source: | Hematology/oncology and stem cell therapy [Hematol Oncol Stem Cell Ther] 2022 Dec 23; Vol. 15 (4), pp. 219-222. Date of Electronic Publication: 2022 Dec 23. |
| Publication Type: | Letter |
| Journal Info: | Publisher: Wolters Kluwer - Medknow Country of Publication: India NLM ID: 101468532 Publication Model: Electronic Cited Medium: Internet ISSN: 2589-0646 (Electronic) Linking ISSN: 25890646 NLM ISO Abbreviation: Hematol Oncol Stem Cell Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2589-0646 |
|---|---|
| DOI: | 10.1016/j.hemonc.2021.07.003 |
